Your browser doesn't support javascript.
loading
Targeted delivery of an anti-inflammatory corticosteroid to Ly6C/G-positive cells abates severity of influenza A symptoms.
Pishesha, Novalia; Harmand, Thibault; Carpenet, Claire; Liu, Xin; Bhan, Atul; Islam, Ashraful; van den Doel, Renate; Pinney, William; Ploegh, Hidde L.
Affiliation
  • Pishesha N; Program in Cellular and Molecular Medicine, Boston Children's Hospital, Harvard Medical School, Boston, MA 02115.
  • Harmand T; Society of Fellows, Harvard University, Cambridge, MA 02138.
  • Carpenet C; Program in Cellular and Molecular Medicine, Boston Children's Hospital, Harvard Medical School, Boston, MA 02115.
  • Liu X; Program in Cellular and Molecular Medicine, Boston Children's Hospital, Harvard Medical School, Boston, MA 02115.
  • Bhan A; Program in Cellular and Molecular Medicine, Boston Children's Hospital, Harvard Medical School, Boston, MA 02115.
  • Islam A; Massachusetts General Hospital, Boston, MA 02114.
  • van den Doel R; Program in Cellular and Molecular Medicine, Boston Children's Hospital, Harvard Medical School, Boston, MA 02115.
  • Pinney W; Program in Cellular and Molecular Medicine, Boston Children's Hospital, Harvard Medical School, Boston, MA 02115.
  • Ploegh HL; Program in Cellular and Molecular Medicine, Boston Children's Hospital, Harvard Medical School, Boston, MA 02115.
Proc Natl Acad Sci U S A ; 119(43): e2211065119, 2022 10 25.
Article in En | MEDLINE | ID: mdl-36252038

Full text: 1 Database: MEDLINE Main subject: Influenza, Human / Single-Domain Antibodies Type of study: Diagnostic_studies Limits: Animals / Humans Language: En Journal: Proc Natl Acad Sci U S A Year: 2022 Type: Article

Full text: 1 Database: MEDLINE Main subject: Influenza, Human / Single-Domain Antibodies Type of study: Diagnostic_studies Limits: Animals / Humans Language: En Journal: Proc Natl Acad Sci U S A Year: 2022 Type: Article